Genetic differences in the IGF-I gene among inbred strains of mice with different serum IGF-I levels.

There is significant heterogeneity in serum IGF-I concentrations among normal healthy individuals across all ages and among inbred strains of mice. C3H/HeJ (C3H) mice have 30% higher serum IGF-I concentrations over a lifetime than C57BL/6J (B6), even though body size and length are identical. The underlying mechanism for this disparity remains unknown although several possibilities exist including altered GH secretion, resistance to GH action, or impaired IGF-I secretion from the liver or peripheral tissues. To study this further, we evaluated mRNA levels of pituitary GH, and of IGF-I, GH receptor (GHR) and acid-labile subunit (ALS) in liver and skeletal muscle of male C3H and B6 strains. mRNA levels of hepatic IGF-I paralleled serum IGF-I levels, whereas pituitary GH mRNA expression was significantly lower in C3H than B6. In addition, reduced hepatic mRNA levels of ALS and GHR in B6 suggests hepatic GH resistance in B6. In contrast, mRNA levels of IGF-I and GHR in skeletal muscle were not different between B6 and C3H. There was a single sequence repeat polymorphism (SSR) in the promoter region of both GHR and IGF-I genes in mice; the SSR in the IGF-I gene was significantly different between the two strains. The SSR in the IGF-I gene corresponds to the E2F binding site, which is critical for regulating IGF-I gene expression. These results suggest that the SSR in the promoter region of the IGF-I gene may be partially responsible for differences in serum IGF-I levels between B6 and C3H strains.

[1]  K. Iida,et al.  Regulation of full-length and truncated growth hormone (GH) receptor by GH in tissues of lit/lit or bovine GH transgenic mice. , 2004, American journal of physiology. Endocrinology and metabolism.

[2]  K. Iida,et al.  Tissue-specific regulation of growth hormone (GH) receptor and insulin-like growth factor-I gene expression in the pituitary and liver of GH-deficient (lit/lit) mice and transgenic mice that overexpress bovine GH (bGH) or a bGH antagonist. , 2004, Endocrinology.

[3]  Z. Laron,et al.  Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003. , 2004, The Journal of clinical endocrinology and metabolism.

[4]  J. Heinrich,et al.  Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit gene. , 2004, The New England journal of medicine.

[5]  M. Permutt,et al.  A single major gene controls most of the difference in susceptibility to streptozotocin-induced diabetes between C57BL/6J and C3H/HeJ mice , 1989, Diabetologia.

[6]  M. Bouxsein,et al.  Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. , 2004, The Journal of clinical investigation.

[7]  P. Rotwein,et al.  Mechanisms of Growth Hormone (GH) Action , 2003, Journal of Biological Chemistry.

[8]  B. Little,et al.  Growth hormone insensitivity associated with a STAT5b mutation. , 2003, The New England journal of medicine.

[9]  K. M. Irvin,et al.  Association of single nucleotide polymorphisms in the growth hormone and growth hormone receptor genes with blood serum insulin-like growth factor I concentration and growth traits in Angus cattle. , 2003, Journal of animal science.

[10]  R. Menon,et al.  Recruitment of a Repressosome Complex at the Growth Hormone Receptor Promoter and Its Potential Role in Diabetic Nephropathy , 2003, Molecular and Cellular Biology.

[11]  K. Sjögren,et al.  Effects of Liver‐Derived Insulin‐Like Growth Factor I on Bone Metabolism in Mice , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  D. Leroith,et al.  Circulating levels of IGF-1 directly regulate bone growth and density. , 2002, The Journal of clinical investigation.

[13]  D. Dunger,et al.  Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study , 2002, The Lancet.

[14]  N. Drinkwater,et al.  The little mutation suppresses DEN-induced hepatocarcinogenesis in mice and abrogates genetic and hormonal modulation of susceptibility. , 2001, Carcinogenesis.

[15]  C. Ohlsson,et al.  Liver-Derived IGF-I Regulates GH Secretion at the Pituitary Level in Mice. , 2001, Endocrinology.

[16]  G. Hendy,et al.  GT repeat polymorphism in the 5' flanking region of the human growth hormone receptor gene. , 2001, Molecular and cellular probes.

[17]  G. Pacini,et al.  Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism. , 2001, Diabetes.

[18]  J. Frystyk,et al.  Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. , 2001, Diabetes.

[19]  D. Stephan,et al.  Identification and characterization of a novel transcript of the murine growth hormone receptor gene exhibiting development- and tissue-specific expression , 2001, Molecular and Cellular Endocrinology.

[20]  G. Churchill,et al.  Mapping quantitative trait loci for serum insulin-like growth factor-1 levels in mice. , 2000, Bone.

[21]  F. Talamantes,et al.  Alternative 5'-untranslated regions of mouse GH receptor/binding protein messenger RNA are derived from sequences adjacent to the major L2 promoter. , 2000, The Journal of endocrinology.

[22]  G. Johnson,et al.  Decreased growth in angus steers with a short TG-microsatellite allele in the P1 promoter of the growth hormone receptor gene. , 2000, Journal of animal science.

[23]  X. E,et al.  Identification of two chromosomal loci determining glucose intolerance in a C57BL/6 mouse strain. , 2000, Comparative medicine.

[24]  D. Shih,et al.  Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism. , 2000, Circulation research.

[25]  E. Rimm,et al.  Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[26]  E. Giovannucci.  Insulin-Like Growth Factor-I and Binding Protein-3 and Risk of Cancer , 1999, Hormone Research in Paediatrics.

[27]  D. Leroith,et al.  Normal growth and development in the absence of hepatic insulin-like growth factor I. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  K. Sjögren,et al.  Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D. Kiel,et al.  Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. , 1998, The Journal of clinical endocrinology and metabolism.

[30]  F. Talamantes,et al.  Alternative processing of growth hormone receptor transcripts. , 1998, Endocrine reviews.

[31]  D. Cooper,et al.  The molecular genetics of growth hormone deficiency , 1998, Human Genetics.

[32]  J. Bilezikian,et al.  Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. , 1998, The Journal of clinical endocrinology and metabolism.

[33]  K. Ogawa,et al.  High colony forming capacity of primary cultured hepatocytes as a dominant trait in hepatocarcinogenesis-susceptible and resistant mouse strains. , 1998, Carcinogenesis.

[34]  M. N. Poy,et al.  Binding of STAT5a and STAT5b to a single element resembling a gamma-interferon-activated sequence mediates the growth hormone induction of the mouse acid-labile subunit promoter in liver cells. , 1998, Molecular endocrinology.

[35]  L. Donahue,et al.  Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities. , 1997, Bone.

[36]  H. Kaji,et al.  Biologically inactive growth hormone caused by an amino acid substitution. , 1997, The Journal of clinical investigation.

[37]  J. Kaprio,et al.  Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. , 1996, The Journal of clinical investigation.

[38]  M. Savage,et al.  Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. , 1996, The New England journal of medicine.

[39]  C. Stewart,et al.  Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. , 1996, Physiological reviews.

[40]  R. Baserga,et al.  Epidermal growth factor and platelet-derived growth factor regulate the activity of the insulin-like growth factor I gene promoter , 1996, Experimental Gerontology.

[41]  高橋 裕.  Short stature caused by a mutant growth hormone , 1996 .

[42]  P. Kao,et al.  Insulin-like growth factor-I comparisons in healthy twin children. , 1994, The Journal of clinical endocrinology and metabolism.

[43]  B. Paigen,et al.  Effects of atherogenic diet consumption on lipoproteins in mouse strains C57BL/6 and C3H. , 1991, Journal of lipid research.

[44]  R. Palmiter,et al.  Expression of insulin-like growth factor I stimulates normal somatic growth in growth hormone-deficient transgenic mice. , 1990, Endocrinology.

[45]  A. Stiles,et al.  Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[46]  K. Abromeit.  Music Received , 2023, Notes.